'Urinary Tract Infection and Levels of HSP-70 In Children as a Sensitive Marker Excluding Other Infections'

Urinary tract infection (UTI) is the most common bacterial infection in children attending emergency departments due to fever. Since the symptoms are non-specific especially in infants, UTI is often confused with other infections.

In patients suspected of having UTI, definitive diagnosis is made only by urine culture several days after admission. International consensus reports recommend to initiate empiric antibiotic treatment in case of suspected UTI. However, only a minor fraction of the patients eventually show significant bacterial growth in their urine culture: Saha et al. reported that empiric antibiotic therapy for presumed UTI was ceased in 84% of cases due to negative culture results, a figure supported by our own unpublished results. This important cause of unnecessary antibiotic treatment increases the risk of bacterial resistance both for the individual patient and at the community level.

In daily practice, urinalysis is commonly used to predict UTI and to decide whether to start treatment. Leukocyturia and urine nitrite test have some important limitations in diagnosing UTI. Sterile pyuria may occur in non-infectious conditions such as urolithiasis, and may be absent in infections with certain bacteria such as Proteus species. Similarly, the nitrite test cannot detect the presence of gram-positive pathogens such as enterococci; the sensitivity of the test is also decreased by high specific gravity of the urine. Urine culture, the definitive diagnostic criterion, is also fraught with methodological issues. Urine samples, usually obtained as mid-stream urine in older children and with collecting bag in infants, may become contaminated with microorganisms from the skin or feces. Moreover, bacterial colonization of the bladder may occur in patients who use intermittent catheterization due to bladder dysfunction. Often the same microorganism is observed in urine cultures consistently even in the absence of infection. While such asymptomatic bacteriuria does not require treatment, it frequently leads to unnecessary antibiotic use.

Given all these shortcomings of the usual diagnostic pathway to UTI, it appears imperative to develop technologies that allow a quick and correct diagnosis at the time of first presentation and to start appropriate treatment without wasting time and financial resources.

Once bacteria reach the urinary tract, the inflammatory response is elicited and renal epithelial cells start producing cytokines and chemokines which, together with antimicrobial peptides such as Hepcidin, Cathelicidin, RNase 7, Secretory leukocyte proteinase inhibitor (SLPI), uromodulin and the defensins, play an active role in the elimination of the infection. Heat shock protein 70 (HSP70) is a member of a protein family upregulated in response to hazardous (stress) factors, including infectious agents. HSP70 activates the Toll-like receptors (TLR), which have a major effect on the immune response. HSP70 is released from macrophages upon exposure to bacterial products, especially Gram-negative bacteria such as Escherichia coli. Hence, urine levels of HSP70 may predict UTI in children with symptoms of systemic infections.

In a pilot study of 40 children with UTI we recently demonstrated that the urine HSP70/creatinine ratio identified and distinguished UTI cases from other infections and cases of urinary bacterial contamination with 100% sensitivity and specificity. Besides, we demonstrated that uHSP70/Cr decreases after UTI treatment and thus may also be used to follow up the response to treatment.

Design:Non-interventional, multicenter, multinational, open, nonrandomized prospective study
Patients enrolled:

400 pediatric patients with symptomatic urinary tract infections
200 asymptomatic children with bacterial contamination in urine culture
400 patients with fever due to other infections
200 children with asymptomatic bacteriuria who urinate with CIC
300 healthy children

Coordinating Center:

Istanbul University Istanbul Faculty of Medicine

Participating Centers:

Germany: Heidelberg, Center for Pediatrics and Adolescent Medicine
Lithuania: Vilnius, Vilnius University Children's Hospital
Serbia: Belgrade, University Children's Hospital
Poland: Gdansk, Medical University; Warsaw, Children's Memorial Health Institute
United Kingdom: London, Great Ormond Street Hospital
Turkey: Adana Cukurova University; Ankara Gazi University; Hacettepe University; Antalya Akdeniz University; Aydin Adnan Menderes University; Bursa Uludag University; Dortcelik Childrens’ Hospital; Denizli Pamukkale University; Edirne Trakya University; Erzurum Educational and Research Hospital;Istanbul Istanbul University Istanbul Faculty of Medicine; Istanbul University Cerrahpasa Faculty of Medicine; Marmara University; Koc University; Bakirkoy Dr. Sadi Konuk Educational and Research Hospital; Bagcilar Educational and Research Hospital; Haseki Educational and Research Hospital; Kanuni Sultan Suleyman Educational and Research Hospital; Kartal Dr. Lutfi Kirdar Educational and Research Hospital; Okmeydani Educational and Research Hospital; Suleymaniye Educational and Research Hospital; Sisli Etfal Educational and Research Hospital; Umraniye Educational and Research Hospital; Izmir Ege University; Dokuz Eylul University ; Dr. Behçet Uz Educational and Research Hospital; Kayseri Erciyes University; Malatya Inonu University; Manisa Celal Bayar University; Samsun 19 Mayis University;Trabzon Karadeniz Teknik University

Contact Information:

Prof. Dr. Alev YILMAZ
Istanbul University Istanbul Faculty of Medicine
Pediatric Nephrology Department
GSM: +905324842309

Test section Frame